Trials / Unknown
UnknownNCT00740441
A Phase II Study of AS1411 in Renal Cell Carcinoma
A Phase II, Open Label, Single Arm Study of AS1411 in Patients With Metastatic Renal Cell Carcinoma
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Antisoma Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the efficacy of AS1411 in patients with Metastatic Renal Cell Carcinoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AS1411 | AS1411 40 mg/kg/day) will be administered on days 1-4 via a continuous iv infusion every 28-day cycle for up to 2 cycles |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2009-09-01
- Completion
- 2010-03-01
- First posted
- 2008-08-25
- Last updated
- 2009-09-25
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00740441. Inclusion in this directory is not an endorsement.